Ciliary body melanoma Ciliary body melanoma Ciliary Body Melanoma is a type of cancer arising from the coloured part (uvea) of the eye. About 12% of uveal melanoma arise from the ciliary body. It occurs most commonly in the sixth decade. The tumour is usually diagnosed by clinical examination with a slit-lamp utilising a triple mirror contact lens. Ultrasonography and fine needle aspiration biopsy (FNAB) are also sometimes helpful in confirming the diagnosis. Enucleation (surgical removal of the eye) is the treatment of choice for large ciliary body melanomas. Small or medium sized tumors may be treated by an "iridocyclectomy". Radiotherapy may be
DecisionDx-UM of the eye which includes the iris, ciliary body, and choroid. Treatment for the primary eye tumor consists of eye-sparing therapy (plaque radiotherapy or proton beam irradiation) or eye removal (enucleation). Both are highly effective with ‘cure’ rates above 90%. However, as has been well documented in multiple publications including the Collaborative Ocular Melanoma Study (COMS), in nearly 50% of patients the melanoma has likely already metastasized by the time the primary eye tumor has been diagnosed and treated. The majority of these metastases are microscopic and clinically undetectable at the time of primary tumor diagnosis. Unfortunately, many of the